← The whole pipeline
Female pattern hair loss
Diffuse thinning across the crown rather than a receding hairline, and the form of hair loss most under-served by the pipeline relative to how common it is.
Most trials in hair loss enrol men. Programmes that specifically recruit women are worth noting for that reason alone, whatever they turn out to be worth.
Available today
- Minoxidil (low-dose oral)Marketed, off-labelUnknownHigh
- Minoxidil (topical)ApprovedUnknownHigh
In development
- Clascoterone (Breezula)Phase 3Cosmo PharmaceuticalsHigh
- N1087Phase 3Eurofarma LaboratóriosLow
- OMA102Phase 3EMSLow
- CKD-498Phase 2Chong Kun Dang PharmaceuticalLow
- PP405Phase 2Pelage PharmaceuticalsHigh
- ANR-001.1 (latanoprost + minoxidil)Phase 0Aneira PharmaLow
This page is generated from the register and updates with it. It does not rank treatments by efficacy or announce launch dates — see how we track.